Drug intelligence / Profile preview

lomefloxacin + nystatin

Development stage: Unknown
Modality: Small Molecules
Administration: Topical, Oral

Overview

This appears to be a combination of lomefloxacin (a fluoroquinolone antibiotic) and nystatin (an antifungal medication). Nystatin is an antifungal that works by damaging the protective covering of fungi, stopping their growth and killing them to treat infections. It is particularly effective against Candida species. The combination would likely be used to treat mixed bacterial and fungal infections, though specific information about this particular combination is not available in the search results.

Targets

Ergosterol

Beyond the preview

Go deeper on lomefloxacin + nystatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lomefloxacin + nystatin.

Explore the full profile